Taiwan Biomaterial Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 11, 2020 at 03:33 am IST
Share
Taiwan Biomaterial Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 1.314 million compared to TWD 3.555 million a year ago. Operating loss was TWD 20.299 million compared to TWD 21.919 million a year ago. Net loss was TWD 19.239 million compared to TWD 21.425 million a year ago. Basic loss per share was TWD 0.58 compared to TWD 0.69 a year ago. For the half year, sales was TWD 2.095 million compared to TWD 3.555 million a year ago. Operating loss was TWD 38.949 million compared to TWD 39.338 million a year ago. Net loss was TWD 37.463 million compared to TWD 38.504 million a year ago. Basic loss per share was TWD 1.14 compared to TWD 1.26 a year ago.
Taiwan Biomaterial Co., Ltd. is a Taiwan-based company mainly engaged in provision of medical equipment. The products are still in research and development stage. The Company's subsidiary TAIWAN MEDICAL RAPID PROTOTYPING CO., LTD.(TRP) is engaged in trial production of medical equipment. Main products include foam artificial meninges products, stroke thrombus aspiration catheter products, repair and regeneration products for early degenerative arthritis and others.
TAIWAN BIOMATERIAL CO., LTD. 
